Pasar al contenido principal

MODELIZACION ESTOCASTICA DE PROCESOS BIOFISICOS A DIFERENTES ESCALAS

PID2022-139215NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POLITECNICA DE CATALUNYA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Real-time prediction of influenza and respiratory syncytial virus epidemics in primary care using the Gompertz model

  • Perramon Malavez, Aida
  • Ye, Qiaoling
  • López, Daniel
  • Montañola-Sales, Cristina
  • Alonso, Sergio
  • Álvarez, Enric
  • Soriano-Arandes, Antoni
  • Prats, Clara
Seasonal epidemics of influenza and respiratory syncytial virus (RSV)-bronchiolitis pose significant challenges for public health systems, requiring timely predictions for effective interventions. In this study, we applied a Gompertz model to cumulative daily primary care diagnoses in Catalonia to predict epidemic peaks and characterize the dynamics of the disease. We estimated RSV-bronchiolitis cases from all-cause bronchiolitis diagnoses and computed epidemic thresholds for the disease. Our approach allowed for peak predictions up to 32 days in advance with an error margin of one week (anticipated). The estimated magnitudes were within 35% error 28 days before the peak and mostly fell within 95% confidence intervals, except for the irregular 2022–2023 RSV-bronchiolitis post-COVID-19 pandemic season. Influenza epidemics exhibited a faster decline, resulting in more symmetrical curves, whereas RSV-bronchiolitis outbreaks were broader, with a higher initial transmission rate. The model operates in real-time without reliance on external assumptions, making it adaptable to changes in epidemiology. However, human intervention to set the models’ parameters enables them to be fitted more precisely, resulting in even better performance through iterative refinement. Our findings highlight the potential of supervised real-time predictive modeling to support epidemic preparedness and optimize healthcare resource allocation., info:eu-repo/semantics/publishedVersion
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

A semi-empirical risk panel to monitor epidemics: multi-faceted tool to assist healthcare and public health professionals

  • Perramon Malavez, Aida|||0000-0002-6057-5127
  • Bravo Masferrer, Mario
  • López de Rioja, Víctor|||0000-0003-4485-0616
  • Català Sabaté, Martí|||0000-0003-3308-9905
  • Alonso Muñoz, Sergio|||0000-0002-3989-8757
  • Álvarez Lacalle, Enrique|||0000-0001-6824-6857
  • López Codina, Daniel|||0000-0002-0408-4526
  • Soriano-Arandes, Antoni
  • Prats Soler, Clara|||0000-0002-1398-7559
Introduction: Bronchiolitis, mostly caused by Respiratory Syncytial Virus (RSV), and influenza among other respiratory infections, lead to seasonal saturation at healthcare centers in temperate areas. There is no gold standard to characterize the stages of epidemics, nor the risk of respiratory infections growing. We aimed to define a set of indicators to assess the risk level of respiratory viral epidemics, based on both incidence and their short-term dynamics, and considering epidemical thresholds. Methods: We used publicly available data on daily cases of influenza for the whole population and bronchiolitis in children <2¿years from the Information System for Infection Surveillance in Catalonia (SIVIC). We included a Moving Epidemic Method (MEM) variation to define epidemic threshold and levels. We pre-processed the data with two different nowcasting approaches and performed a 7-day moving average. Weekly incidences (cases per 105 population) were computed and the 5-day growth rate was defined to create the effective potential growth (EPG) indicator. We performed a correlation analysis to define the forecasting ability of this index. Results: Our adaptation of the MEM method allowed us to define epidemic weekly incidence levels and epidemic thresholds for bronchiolitis and influenza. EPG was able to anticipate daily 7-day cumulative incidence by 4–5 (bronchiolitis) or 6–7 (influenza) days. Discussion: We developed a semi-empirical risk panel incorporating the EPG index, which effectively anticipates surpassing epidemic thresholds for bronchiolitis and influenza. This panel could serve as a robust surveillance tool, applicable to respiratory infectious diseases characterized by seasonal epidemics, easy to handle for individuals lacking a mathematical background., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Grant number 202134-30-31, funded by “La Fundació La Marató de TV3.” Grant PDI2022-139215NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe.”, Peer Reviewed, Objectius de Desenvolupament Sostenible::3 - Salut i Benestar
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Introduction of nirsevimab in Catalonia, Spain: description of the incidence of bronchiolitis and respiratory syncytial virus in the 2023/2024 season

  • Perramon Malavez, Aida|||0000-0002-6057-5127
  • López de Rioja, Víctor|||0000-0003-4485-0616
  • Coma, Ermengol
  • Hermosilla, Eduardo
  • Fina, Francesc
  • Martínez-Marcos, Montserrat
  • Mendioroz Peña, Jacobo
  • Cabezas Peña, Carmen
  • Montañola Sales, Cristina|||0000-0001-5893-3709
  • Prats Soler, Clara|||0000-0002-1398-7559
  • Soriano-Arandes, Antoni
Respiratory syncytial virus (RSV) causes most of the cases of bronchiolitis and thousands of deaths annually, particularly in infants less than 6 months old. In Catalonia (Spain), infants born between April 2023 and March 2024 aged 0–6 months during their frst RSV season have been candidates to receive nirsevimab, the novel monoclonal antibody against RSV, since October 2023. We aimed to analyse the dynamics of all-causes bronchiolitis diagnoses and RSV community infections in the current season and compare them to pre-nirsevimab epidemics. We collected epidemiological data from the Information System for Surveillance of Infections in Catalonia (SIVIC) on daily all-causes bronchiolitis clinical diagnoses and RSV-confrmed cases provided by rapid antigen tests in primary care practices. We calculated the rate ratio (RR) for the incidence of all-causes bronchiolitis for children aged 0-11 m-old with respect to 12-35 m-old between September 2014 and January 2024. We analysed the RR of the incidence of RSV-confrmed infection for 0-11 m-old and 12-35 m-old with respect to the>35 m-old, from January 2021 to January 2024. We then computed the relative diference of the RR, designated as percentage of reduction of risk, between season 2023/2024 and former epidemics. With a global coverage recorded rate for nirsevimab of 82.2% in January 2024, the age-specifc 0-11 m-old RR (95% CI) of RSV infection incidence for>35 m-old was 1.7 (1.5–2.0) in season 2023/2024. The RR (95% CI) had been 7.4 (5.6–9.9), 8.8 (6.9–11.3), and 7.1 (5.7–8.9) in 2020/2021, 2021/2022, and 2022/2023, respectively. Regarding the incidence of all-causes bronchiolitis for the 0-11 m-old group compared to the 12-35 m-old, the pre-pandemic (2014/2015–2019/2020) and 2022/2023 RR (95% CI) were 9.4 (9.2–9.6) and 6.0 (5.7–6.2), respectively, signifcantly higher than the RR of 3.6 (3.4–3.8) for the most recent season, 2023/2024. Conclusion: Concurring with the introduction of nirsevimab, the risk of RSV infection for infants aged 0-11 m-old compared to>35 m-old has been reduced by 75.6% (73.4–77.5) in last season, and the risk for all-causes bronchiolitis for 12-35 m-old by 61.9% (60.9–62.9) from the pre-pandemic period and by 39.8% (39.3–40.2) from the 2022/2023 epidemic, despite high RSV community transmission, especially in older infants., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The author(s) declare financial sup- port was received for the research, authorship, and/or publication of this article. ASA has received honoraria for attending scientific meetings from Sanofi, MSD, and Pfizer. Funding was also received from grant number 202134–30-31, funded by “La Fundació La Marató de TV3”, and grant PDI2022-139215NB-I00 funded by MCIN/AEI/https://doi. org/10.13039/501100011033and by “ERDF A way of making Europe”., Peer Reviewed, Objectius de Desenvolupament Sostenible::3 - Salut i Benestar
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Subconductance states in a semimicroscopic model for a tetrameric pore

  • Ramírez de la Piscina Millán, Laureano|||0000-0003-4019-245X
  • Sancho, Jose María
A physical model for a structured tetrameric pore is studied. The pore is modeled as a device composed of four subunits, each one exhibiting two possible states (open and closed). The pore is located within a membrane that separates two reservoirs with ionic solutions. All variables of the model follow physical dynamical equations accounting for the internal structure of the pore, derived from a single energy functional and supplemented with thermal noises. An extensive study of the resulting ionic intensity is performed for different values of the control parameters, mainly membrane potential and reservoir ion concentrations. Two possible physical devices are studied: voltage-gated (including a voltage sensor in each subunit) and non-voltage-gated pores. The ionic flux through the pore exhibits several distinct dynamical configurations, in particular subconductance states, which indicate very different dynamical internal states of the subunits. Such subconductance states become much easier to observe in sensorless pores. These results are compared with available experimental data on tetrameric K channels and analytical predictions., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Real-time prediction of influenza and respiratory syncytial virus epidemics in primary care using the Gompertz model

  • Perramon Malavez, Aida
  • Ye, Qiaoling
  • López, Daniel
  • Montañola-Sales, Cristina
  • Alonso, Sergio
  • Álvarez, Enric
  • Soriano-Arandes, Antoni
  • Prats, Clara
Seasonal epidemics of influenza and respiratory syncytial virus (RSV)-bronchiolitis pose significant challenges for public health systems, requiring timely predictions for effective interventions. In this study, we applied a Gompertz model to cumulative daily primary care diagnoses in Catalonia to predict epidemic peaks and characterize the dynamics of the disease. We estimated RSV-bronchiolitis cases from all-cause bronchiolitis diagnoses and computed epidemic thresholds for the disease. Our approach allowed for peak predictions up to 32 days in advance with an error margin of one week (anticipated). The estimated magnitudes were within 35% error 28 days before the peak and mostly fell within 95% confidence intervals, except for the irregular 2022–2023 RSV-bronchiolitis post-COVID-19 pandemic season. Influenza epidemics exhibited a faster decline, resulting in more symmetrical curves, whereas RSV-bronchiolitis outbreaks were broader, with a higher initial transmission rate. The model operates in real-time without reliance on external assumptions, making it adaptable to changes in epidemiology. However, human intervention to set the models’ parameters enables them to be fitted more precisely, resulting in even better performance through iterative refinement. Our findings highlight the potential of supervised real-time predictive modeling to support epidemic preparedness and optimize healthcare resource allocation., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A semi-empirical risk panel to monitor epidemics: multi-faceted tool to assist healthcare and public health professionals

  • Perramon Malavez, Aida
  • Bravo Masferrer, Mario
  • López de Rioja, Víctor
  • Català Sabaté, Martí
  • Alonso Muñoz, Sergio
  • Álvarez Lacalle, Enrique
  • López Codina, Daniel
  • Soriano Arandes, Antoni
  • Prats Soler, Clara
Introduction: Bronchiolitis, mostly caused by Respiratory Syncytial Virus (RSV), and influenza among other respiratory infections, lead to seasonal saturation at healthcare centers in temperate areas. There is no gold standard to characterize the stages of epidemics, nor the risk of respiratory infections growing. We aimed to define a set of indicators to assess the risk level of respiratory viral epidemics, based on both incidence and their short-term dynamics, and considering epidemical thresholds. Methods: We used publicly available data on daily cases of influenza for the whole population and bronchiolitis in children <2¿years from the Information System for Infection Surveillance in Catalonia (SIVIC). We included a Moving Epidemic Method (MEM) variation to define epidemic threshold and levels. We pre-processed the data with two different nowcasting approaches and performed a 7-day moving average. Weekly incidences (cases per 105 population) were computed and the 5-day growth rate was defined to create the effective potential growth (EPG) indicator. We performed a correlation analysis to define the forecasting ability of this index. Results: Our adaptation of the MEM method allowed us to define epidemic weekly incidence levels and epidemic thresholds for bronchiolitis and influenza. EPG was able to anticipate daily 7-day cumulative incidence by 4–5 (bronchiolitis) or 6–7 (influenza) days. Discussion: We developed a semi-empirical risk panel incorporating the EPG index, which effectively anticipates surpassing epidemic thresholds for bronchiolitis and influenza. This panel could serve as a robust surveillance tool, applicable to respiratory infectious diseases characterized by seasonal epidemics, easy to handle for individuals lacking a mathematical background., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Grant number 202134-30-31, funded by “La Fundació La Marató de TV3.” Grant PDI2022-139215NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe.”, Peer Reviewed, Objectius de Desenvolupament Sostenible::3 - Salut i Benestar, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Introduction of nirsevimab in Catalonia, Spain: description of the incidence of bronchiolitis and respiratory syncytial virus in the 2023/2024 season

  • Perramon Malavez, Aida
  • López de Rioja, Víctor
  • Coma, Ermengol
  • Hermosilla, Eduardo
  • Fina, Francesc
  • Martínez-Marcos, Montserrat
  • Mendioroz Peña, Jacobo
  • Cabezas Peña, Carmen
  • Montañola Sales, Cristina
  • Prats Soler, Clara
  • Soriano Arandes, Antoni
Respiratory syncytial virus (RSV) causes most of the cases of bronchiolitis and thousands of deaths annually, particularly in infants less than 6 months old. In Catalonia (Spain), infants born between April 2023 and March 2024 aged 0–6 months during their frst RSV season have been candidates to receive nirsevimab, the novel monoclonal antibody against RSV, since October 2023. We aimed to analyse the dynamics of all-causes bronchiolitis diagnoses and RSV community infections in the current season and compare them to pre-nirsevimab epidemics. We collected epidemiological data from the Information System for Surveillance of Infections in Catalonia (SIVIC) on daily all-causes bronchiolitis clinical diagnoses and RSV-confrmed cases provided by rapid antigen tests in primary care practices. We calculated the rate ratio (RR) for the incidence of all-causes bronchiolitis for children aged 0-11 m-old with respect to 12-35 m-old between September 2014 and January 2024. We analysed the RR of the incidence of RSV-confrmed infection for 0-11 m-old and 12-35 m-old with respect to the>35 m-old, from January 2021 to January 2024. We then computed the relative diference of the RR, designated as percentage of reduction of risk, between season 2023/2024 and former epidemics. With a global coverage recorded rate for nirsevimab of 82.2% in January 2024, the age-specifc 0-11 m-old RR (95% CI) of RSV infection incidence for>35 m-old was 1.7 (1.5–2.0) in season 2023/2024. The RR (95% CI) had been 7.4 (5.6–9.9), 8.8 (6.9–11.3), and 7.1 (5.7–8.9) in 2020/2021, 2021/2022, and 2022/2023, respectively. Regarding the incidence of all-causes bronchiolitis for the 0-11 m-old group compared to the 12-35 m-old, the pre-pandemic (2014/2015–2019/2020) and 2022/2023 RR (95% CI) were 9.4 (9.2–9.6) and 6.0 (5.7–6.2), respectively, signifcantly higher than the RR of 3.6 (3.4–3.8) for the most recent season, 2023/2024. Conclusion: Concurring with the introduction of nirsevimab, the risk of RSV infection for infants aged 0-11 m-old compared to>35 m-old has been reduced by 75.6% (73.4–77.5) in last season, and the risk for all-causes bronchiolitis for 12-35 m-old by 61.9% (60.9–62.9) from the pre-pandemic period and by 39.8% (39.3–40.2) from the 2022/2023 epidemic, despite high RSV community transmission, especially in older infants., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The author(s) declare financial sup- port was received for the research, authorship, and/or publication of this article. ASA has received honoraria for attending scientific meetings from Sanofi, MSD, and Pfizer. Funding was also received from grant number 202134–30-31, funded by “La Fundació La Marató de TV3”, and grant PDI2022-139215NB-I00 funded by MCIN/AEI/https://doi. org/10.13039/501100011033and by “ERDF A way of making Europe”., Peer Reviewed, Objectius de Desenvolupament Sostenible::3 - Salut i Benestar, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Subconductance states in a semimicroscopic model for a tetrameric pore

  • Ramírez de la Piscina Millán, Laureano
  • Sancho, Jose María
A physical model for a structured tetrameric pore is studied. The pore is modeled as a device composed of four subunits, each one exhibiting two possible states (open and closed). The pore is located within a membrane that separates two reservoirs with ionic solutions. All variables of the model follow physical dynamical equations accounting for the internal structure of the pore, derived from a single energy functional and supplemented with thermal noises. An extensive study of the resulting ionic intensity is performed for different values of the control parameters, mainly membrane potential and reservoir ion concentrations. Two possible physical devices are studied: voltage-gated (including a voltage sensor in each subunit) and non-voltage-gated pores. The ionic flux through the pore exhibits several distinct dynamical configurations, in particular subconductance states, which indicate very different dynamical internal states of the subunits. Such subconductance states become much easier to observe in sensorless pores. These results are compared with available experimental data on tetrameric K channels and analytical predictions., Peer Reviewed, Postprint (author's final draft)